Matches in Wikidata for { <http://www.wikidata.org/entity/Q77304051> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q77304051 description "article scientifique publié en 2001" @default.
- Q77304051 description "artículu científicu espublizáu en payares de 2001" @default.
- Q77304051 description "im November 2001 veröffentlichter wissenschaftlicher Artikel" @default.
- Q77304051 description "scientific article published on 01 November 2001" @default.
- Q77304051 description "wetenschappelijk artikel" @default.
- Q77304051 description "наукова стаття, опублікована в листопаді 2001" @default.
- Q77304051 name "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 name "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 type Item @default.
- Q77304051 label "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 label "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 prefLabel "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 prefLabel "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 P1433 Q77304051-3D9BF827-8FA7-446E-8AED-8174526F4181 @default.
- Q77304051 P1476 Q77304051-FA5949F0-117B-428F-99A5-FBFC9537AE34 @default.
- Q77304051 P2093 Q77304051-8FF8972C-1302-4240-9EAF-F4A7BBB1C869 @default.
- Q77304051 P304 Q77304051-33859FAE-DA75-4D67-B44D-84D9536E198D @default.
- Q77304051 P31 Q77304051-ED364558-FD0D-4BC3-AD99-4EA301189573 @default.
- Q77304051 P433 Q77304051-CEE5A344-3BE1-431A-962A-C3AAA3FD5A1F @default.
- Q77304051 P478 Q77304051-54899FA7-184E-454B-972F-5FEAA7330159 @default.
- Q77304051 P577 Q77304051-1718A020-445E-456B-9F50-20BC1C45D23E @default.
- Q77304051 P698 Q77304051-E45A10AA-09B3-42BC-9312-4857B1D352A4 @default.
- Q77304051 P921 Q77304051-85D19500-9E48-4603-AB22-01ADEAB63A18 @default.
- Q77304051 P921 Q77304051-AD41B7D7-D54C-47EE-AE4A-20C28BBCDF41 @default.
- Q77304051 P698 11727395 @default.
- Q77304051 P1433 Q15807020 @default.
- Q77304051 P1476 "Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies" @default.
- Q77304051 P2093 "Burkman RT" @default.
- Q77304051 P304 "S571-4" @default.
- Q77304051 P31 Q13442814 @default.
- Q77304051 P433 "18 Suppl" @default.
- Q77304051 P478 "7" @default.
- Q77304051 P577 "2001-11-01T00:00:00Z" @default.
- Q77304051 P698 "11727395" @default.
- Q77304051 P921 Q108667313 @default.
- Q77304051 P921 Q122224 @default.